[1]
A. O. Saleh, R. Taha, S. F. A. Mohamed, and M. Bashir, “Hyperosmolar Hyperglycaemic State and Diabetic Ketoacidosis in Nivolumab-Induced Insulin-Dependent Diabetes Mellitus”, EJCRIM, vol. 8, no. 8, Aug. 2021, doi: 10.12890/2021_002756.